BMS Buoyed By EU Approval Of Myelofibrosis Drug

Inrebic Came From Celgene Acquisition

There have been lots of twists and turns on the development path for Inrebic which is now the second JAK inhibitor to be approved in the EU for MF since the blockbuster Jakavi was cleared in 2012.

eu flag
Warm welcome in EU for Inrebic • Source: Shutterstock

More from Anticancer

More from Therapy Areas